drugset / Trial / NCT06639997

Safety and Tolerability of AZD5148 in Japanese Participants

NCT06639997 ↗

Phase 1 Completed 16 enrolled AstraZeneca
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to measure safety, tolerability and PK of a single dose of AZD5148 administered via IV bolus or IM injection in healthy Japanese participants.

Timeline

Start
2024-10-31
Primary completion
2025-12-25
Completion
2025-12-25

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD5148 Monoclonal antibody — Intramuscular